This study showed that FAM49B can activate the proliferation and metastasis of BC cells through the ELAVL1/Rab10/TLR4 pathway, and the malignant degree and aggressiveness of breast cancer with high expression of FAM49B were significantly increased. Here, CYRIB is linked to breast carcinoma.